The operational cash flow from the existing non acute sector business is actually OK, the issue is simply how much of this to risk on R & D and marketing. Obviously they will manage cash flow so they do not run out. It simply comes down to whether the R & D and marketing delivers in the couple of years. Its not a given.
Ann: 5th Consecutive Year of Profit, page-11
Add GLH (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
13.5¢ |
Change
0.005(3.85%) |
Mkt cap ! $7.836M | |||
| Open | High | Low | Value | Volume |
| 13.0¢ | 13.5¢ | 13.0¢ | $6.465K | 48.07K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 39384 | 13.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 13.5¢ | 1585 | 1 |
View Market Depth
| Last trade - 15.35pm 29/11/2024 (20 minute delay) ? |
| GLH (ASX) Chart |
